Literature DB >> 4569061

Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.

G Falkson, A M Van der Merwe, H C Falkson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4569061

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  3 in total

1.  [Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].

Authors:  R Preussmann; S Ivankovic; C Landschütz; J Gimmy; E Flohr; U Griesbach
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

2.  Phase II trial of fotemustine in patients with metastatic malignant melanoma.

Authors:  C I Falkson; G Falkson; H C Falkson
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.

Authors:  C I Falkson
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.